Sensus Healthcare Inc
$ 4.49
1.35%
14 Apr - close price
- Market Cap 73,915,000 USD
- Current Price $ 4.49
- High / Low $ 4.55 / 4.34
- Stock P/E N/A
- Book Value 1.57
- EPS -0.47
- Next Earning Report 2026-05-21
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.11 %
- ROE -0.15 %
- 52 Week High 5.92
- 52 Week Low 3.03
About
Sensus Healthcare, Inc. manufactures, distributes and markets superficial radiation therapy devices to healthcare providers worldwide. The company is headquartered in Boca Raton, Florida.
Analyst Target Price
$6.88
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-12 | 2025-11-14 | 2025-08-07 | 2025-05-15 | 2025-02-05 | 2024-11-14 | 2024-08-08 | 2024-05-09 | 2024-02-08 | 2023-11-09 | 2023-08-03 | 2023-05-03 |
| Reported EPS | -0.19 | -0.06 | -0.06 | -0.16 | 0.09 | 0.07 | 0.1 | 0.14 | 0.26 | -0.09 | -0.02 | -0.12 |
| Estimated EPS | -0.04 | -0.08 | 0.01 | 0.02 | 0.12 | -0.01 | 0.02 | -0.05 | 0.12 | -0.02 | -0.08 | 0.13 |
| Surprise | -0.15 | 0.02 | -0.07 | -0.18 | -0.03 | 0.08 | 0.08 | 0.19 | 0.14 | -0.07 | 0.06 | -0.25 |
| Surprise Percentage | -375% | 25% | -700% | -900% | -25% | 800% | 400% | 380% | 116.6667% | -350% | 75% | -192.3077% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-21 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: SRTS
2026-03-27 12:39:14
Sensus Healthcare, Inc. (NASDAQ:SRTS) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $6.875. This comes despite the company missing Q4 earnings and revenue estimates and showing negative financial metrics. Several institutional investors have recently adjusted their holdings in SRTS.
2026-03-27 12:10:15
Sensus Healthcare, Inc. announced it has filed a lawsuit against SkinCure Oncology, LLC for breach of contract. Sensus alleges that SkinCure failed to pay for millions of dollars worth of medical equipment, specifically 10 SRT-100 Vision Products, that have been delivered, accepted, and are in clinical use since August 2025. Sensus Healthcare stated it will vigorously pursue legal remedies to enforce its contractual rights and does not expect the lawsuit to impact its global customer support or commercial strategy.
2026-03-27 11:39:14
Sensus Healthcare Inc. has filed a lawsuit against SkinCure Oncology LLC for breach of contract, alleging SkinCure failed to pay millions of dollars for 10 SRT-100 Vision products. The medical device company states the equipment has been in clinical use since August 2025 and seeks unspecified damages. Despite this, Sensus Healthcare maintains a strong balance sheet and does not expect the lawsuit to impact its operations or commercial strategy, even as it recently reported a significant miss in Q4 2025 earnings.
2026-03-27 11:39:14
Sensus Healthcare has filed a lawsuit against Skincure Oncology, alleging breach of contract. This news was reported by Reuters and indicates a legal dispute between the two companies. The lawsuit is of interest to investors tracking mergers and acquisitions in the US stock market.
2026-03-27 11:06:00
Sensus Healthcare Inc. has filed a lawsuit against SkinCure Oncology LLC for breach of contract over unpaid medical equipment, specifically 10 SRT-100 Vision products. The lawsuit seeks unspecified damages, interest, and legal costs, with Sensus CEO Joe Sardano stating that SkinCure acknowledges the debt but has failed to pay. Despite the legal action, Sensus Healthcare states that it does not expect the matter to affect its operations or commercial strategy and has recently introduced new products and financing options.
2026-03-27 08:00:00
Sensus Healthcare, Inc. has filed a lawsuit against SkinCure Oncology, LLC in Florida, alleging breach of contract. Sensus claims SkinCure owes millions for medical equipment that has been delivered, accepted, and deployed since August 2025. Sensus Healthcare is seeking to recover these unpaid amounts, along with damages, interest, and legal costs.
